Stock Research for PBYI


Featured Broker: Ally Invest

Get the due diligence for another stock.


PBYI Stock Chart & Research Data

The PBYI chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the PBYI chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


PBYI Due diligence Resources & Stock Charts

The PBYI stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View PBYI Detailed Price Forecast - CNN Money CNN View PBYI Detailed Summary - Google Finance
Yahoo View PBYI Detailed Summary - Yahoo! Finance Zacks View PBYI Stock Research & Analysis -

Stock Analysis

TradeIdeas View PBYI Trends & Analysis - Trade-Ideas Barrons View PBYI Major Holders - Barrons
NASDAQ View PBYI Call Transcripts - NASDAQ Seeking View PBYI Breaking News & Analysis - Seeking Alpha
Spotlight View PBYI Annual Report - OTC Report View PBYI OTC Short Report -
TradeKing View PBYI Fundamentals - TradeKing Charts View PBYI SEC Filings - Bar Chart
WSJ View Historical Prices for PBYI - The WSJ Morningstar View Performance/Total Return for PBYI - Morningstar
MarketWatch View the Analyst Estimates for PBYI - MarketWatch CNBC View the Earnings History for PBYI - CNBC
StockMarketWatch View the PBYI Earnings - StockMarketWatch MacroAxis View PBYI Buy or Sell Recommendations - MacroAxis
Bullish View the PBYI Bullish Patterns - American Bulls Short Pains View PBYI Short Pain Metrics -

Social Media Mentions

StockTwits View PBYI Stock Mentions - StockTwits PennyStocks View PBYI Stock Mentions - PennyStockTweets
Twitter View PBYI Stock Mentions - Twitter Invest Hub View PBYI Investment Forum News - Investor Hub
Yahoo View PBYI Stock Mentions - Yahoo! Message Board Seeking Alpha View PBYI Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for PBYI - Insider Cow View Insider Transactions for PBYI - Insider Cow
CNBC View PBYI Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for PBYI - OTC Markets
Yahoo View Insider Transactions for PBYI - Yahoo! Finance NASDAQ View Institutional Holdings for PBYI - NASDAQ

Stock Charts

FinViz View PBYI Stock Insight & Charts - StockCharts View PBYI Investment Charts -
BarChart View PBYI Stock Overview & Charts - BarChart Trading View View PBYI User Generated Charts - Trading View

Latest Financial News for PBYI

Puma Biotechnology to Host Conference Call to Discuss Third Quarter Financial Results
Posted on Thursday October 18, 2018

Puma Biotechnology, Inc. (PBYI), a biopharmaceutical company, will host a conference call at 1:30 p.m. PDT/4:30 p.m. EDT on Thursday, November 1, 2018 following release of its third quarter 2018 financial results. Please dial in at least ten minutes in advance and inform the operator that you would like to join the “Puma Biotechnology Conference Call.” A live webcast of the conference call and presentation slides may be accessed on the Investors section of the Puma Biotechnology website at A replay of the call will be available approximately one hour after completion of the call and will be archived on Puma’s website for 90 days.

Puma Biotech (PBYI) Rides High on Robust Nerlynx Performance
Posted on Thursday October 18, 2018

Puma Biotech (PBYI) focuses on improving sales of its flagship and the only approved product Nerlynx. The drug's label expansion programs also appear promising.

Investor Expectations to Drive Momentum within Arsanis, Dynavax Technologies, Puma Biotechnology, Opko Health, Adaptimmune Therapeutics, and Codexis — Discovering Underlying Factors of Influence
Posted on Wednesday October 17, 2018

NEW YORK, Oct. 17, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.

Celcuity Announces Clinical Trial Collaboration with Puma Biotechnology and West Cancer Center
Posted on Tuesday October 16, 2018

Celcuity Inc. (CELC), a functional cellular analysis company that is discovering new cancer subtypes and commercializing diagnostic tests designed to significantly improve clinical outcomes of cancer patients treated with targeted therapies, today announced a clinical trial agreement with Puma Biotechnology, Inc. (PBYI), a biopharmaceutical company, and West Cancer Center, to conduct a Phase II clinical trial. This open-label Phase II trial will evaluate the efficacy and safety of Puma’s drug, NERLYNX ®(neratinib), and chemotherapy in up to 27 early stage triple-negative breast cancer patients selected with Celcuity’s CELx HER2 Signaling Function (“CELx HSF”) Test. Under this agreement, West Cancer Center will serve as the sponsor and principal investigator of the trial and is responsible for enrolling patients and managing clinical data.

Stock Market & Investing Books

Enter a stock symbol to view the stock details.